ASCLEPIX THERAPEUTICS
AsclepiX Therapeutics represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular), and anti-lymphangiogenic peptides. They also use the latest developments in biomaterials and drug delivery to design long-lasting biodegradable nano and microparticles to deliver these biomimetic therapeutic peptides throughout the body. AsclepiX Therapeutics utilizes its platform technology for indications in ophthalmology, oncology, and for other angiogenesis and lymphangiogenesis-dependent diseases.
ASCLEPIX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2011-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.asclepix.com
Total Employee:
11+
Status:
Active
Contact:
410-657-2627
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Domain Not Resolving Euro CrUX Top 50m CrUX Dataset
Similar Organizations
Alaya Bioscience
Alaya Bioscience is a biotech company that develops novel nanotherapeutics for the treatment of human diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series A - AsclepiX Therapeutics
Hibiscus Capital Management
Hibiscus Capital Management investment in Series A - AsclepiX Therapeutics
Rapha Capital Management
Rapha Capital Management investment in Series A - AsclepiX Therapeutics
Barer & Son Capital
Barer & Son Capital investment in Series A - AsclepiX Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series A - AsclepiX Therapeutics
Rapha Capital Management
Rapha Capital Management investment in Series A - AsclepiX Therapeutics
Salem Partners
Salem Partners investment in Convertible Note - AsclepiX Therapeutics
Rapha Capital Management
Rapha Capital Management investment in Convertible Note - AsclepiX Therapeutics
Piedmont Capital Partners
Piedmont Capital Partners investment in Convertible Note - AsclepiX Therapeutics
Barer & Son Capital
Barer & Son Capital investment in Convertible Note - AsclepiX Therapeutics
Official Site Inspections
http://www.asclepix.com Semrush global rank: 10.25 M Semrush visits lastest month: 240
Unable to get host informations!!!
More informations about "AsclepiX Therapeutics"
About - AsclepiX Therapeutics
Prior to joining AsclepiX Therapeutics, Dr. Sheng served as Sr. Director of Clinical Research and Drug Safety at Aerie Pharmaceuticals, where she was responsible for the development and …See details»
AsclepiX Therapeutics - LinkedIn
AsclepiX Therapeutics is a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and develop peptides for improved treatments of retinal …See details»
AsclepiX Therapeutics - Crunchbase Company Profile
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.See details»
AsclepiX Therapeutics - 2025 Company Profile & Team - Tracxn
Jun 19, 2025 Explore AsclepiX Therapeutics' in-depth company profile, including funding details, key investors, leadership, and competitors.See details»
AsclepiX Therapeutics Company Profile | Management and
Find contact information for AsclepiX Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and AsclepiX Therapeutics's email format.See details»
AsclepiX Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for AsclepiX Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Asclepix Therapeutics, Inc. Company Profile | Baltimore, MD ...
Find company research, competitor information, contact details & financial data for Asclepix Therapeutics, Inc. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
AsclepiX Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
Jul 6, 2025 Explore AsclepiX Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 17 news, and 2 literature, Disease Domain ...See details»
AsclepiX Therapeutics Company Profile - Craft
AsclepiX Therapeutics has 5 employees across 2 locations and $40 m in total funding,. See insights on AsclepiX Therapeutics including office locations, competitors, revenue, financials, …See details»
AsclepiX Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View AsclepiX Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
AsclepiX Therapeutics: Revenue, Worth, Valuation & Competitors …
AsclepiX Therapeutics is a Biotech related company based in Jersey City with 7 employees an estimated revenue of $2.5M, and. It has 10 competitors including Dermavant Sciences, …See details»
Our Team — Humonix Biosciences
Robert Dempsey, CEO, Asclepix Therapeutics Robert Dempsey is the Chief Executive Officer and President of Asclepix Therapeutics. Previously, he served as Chief Executive Officer of …See details»
AsclepiX Therapeutics Inc - Company Profile and News
Oct 11, 2018 Company profile page for AsclepiX Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
AsclepiX Therapeutics | CipherBio
Explore AsclepiX Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
AsclepiX Therapeutics | Biotech Careers
AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to …See details»
AsclepiX Therapeutics - Funding, Financials, Valuation & Investors
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.See details»
AsclepiX Therapeutics Announces $35 Million Series A Financing
BALTIMORE, MD, June 24, 2020 – AsclepiX Therapeutics, Inc., a biopharmaceutical company that uses computational biology to identify potent peptide regulators of vascular homeostasis …See details»
AsclepiX Therapeutics - Contacts, Employees, Board Members, …
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.See details»
Jill Vazzano Tierney - Vice President Finance - AsclepiX ... - LinkedIn
· Experience: AsclepiX Therapeutics · Location: New York City Metropolitan Area · 500+ connections on LinkedIn. View Jill Vazzano Tierney’s profile on LinkedIn, a professional …See details»
AsclepiX Therapeutics, Inc. Strengthens Board of Directors, …
AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing novel peptide therapies, including AXT107 for retinal disease and novel peptides for cancer, adds Steven M. …See details»